ArticleGut2023

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-control study.

Pui San Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.